TE_38965
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluSz |
|---|---|
| TE superfamily | Alu |
| TE class | SINE |
| Gene | -, ENSG00000286201 |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 1.80 |
| Counts of samples | TCGA_tumor:152; TCGA_normal:16; GTEx:79 |
| TSS | chrY(-):16619606 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38965.1 | ENSG00000286201 | Chimeric | Non-coding | Non-coding | chrY(-):16605823,16605843,16607825,16615789,16619471,16619607 |
| teRNA_38965.2 | ENSG00000286201 | Chimeric | Non-coding | Non-coding | chrY(-):16605823,16605843,16607825,16607947,16619471,16619607 |
| teRNA_38965.3 | - | Intergenic | Non-coding | Non-coding | chrY(-):16601564,16601584,16605727,16607947,16619471,16619607 |
| teRNA_38965.4 | ENSG00000286201 | Chimeric | Non-coding | Non-coding | chrY(-):16605823,16605843,16611146,16611219,16619471,16619607 |
| teRNA_38965.5 | ENSG00000286201 | Chimeric | Non-coding | Non-coding | chrY(-):16605823,16605843,16607825,16611219,16619471,16619607 |
| teRNA_38965.6 | - | Intergenic | Non-coding | Non-coding | chrY(-):16607927,16607947,16611146,16611219,16619471,16619607 |
| teRNA_38965.7 | ENSG00000286201 | Chimeric | Non-coding | Non-coding | chrY(-):16605823,16605843,16607825,16607947,16611146,16611219,16619471,16619607 |
| teRNA_38965.8 | - | Intergenic | Non-coding | Non-coding | chrY(-):16601564,16601584,16611146,16611219,16619471,16619607 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
